Articles From: OPKO Health Announces Key Executive Appointments for Renal Division to OPMEDIC GROUP Inc. announces the acquisition of the operations of Heartland Fertility and Gynecology Clinic in Winnipeg


2014/4/3
OPKO Health, Inc. (NYSE: OPK ) today announced the hiring of key executives for its Renal Division.
Sign-up for OPKO Health Announces Key Executive Appointments for Renal Division investment picks
2013/8/28
OPKO Health, Inc. (NYSE: OPK) , a multi-national biopharmaceutical and diagnostics company, today announced that OPKO's common stock, which began trading on the Tel-Aviv Stock Exchange ("TASE") on August 21, 2013, will be included, effective October 6, 2013, in the following major TASE indices: Tel Aviv 25, Tel Aviv 100, Tel Aviv Composite, Tel Aviv Biomed, and Tel Aviv BlueTech-50.
Sign-up for OPKO Health Announces Listing in Major Indices on Tel Aviv Stock Exchange investment picks
2013/8/19
OPKO Health, Inc. (NYSE: OPK) , a multi-national biopharmaceutical and diagnostics company, today announced that the Tel-Aviv Stock Exchange (“TASE”) has approved the new listing of OPKO’s common stock on the TASE beginning on August 21, 2013, under the ticker symbol OPK.
Sign-up for OPKO Health Announces New Listing on Tel Aviv Stock Exchange investment picks
2014/2/6
OPKO Health, Inc. (NYSE:OPK) is pleased to announce the appointment of Greg Stanley as Vice President of Sales and Marketing for its global diagnostics business unit.
Sign-up for OPKO Health Announces the Appointment of Greg Stanley as Vice President of Sales and Marketing for its Global Diagnostics Business Unit investment picks
2014/1/8
OPKO Health, Inc. (NYSE: OPK ) has completed the acquisition of Laboratorio Arama de Uruguay Limitada ("Arama"). Domiciled in Montevideo, Uruguay, Arama adds to our growing Latin American presence in the important Mercosur economic region and complements our business activities in Chile, Mexico and Brazil.
Sign-up for OPKO Health Completes Acquisition of Laboratorio Arama de Uruguay Limitada investment picks
OPKO Health, Inc. (NYSE: OPK ) has entered into an agreement to acquire Laboratorio Arama de Uruguay Limitada (“Arama”). Domiciled in Montevideo, Uruguay, Arama will add to our growing South American presence in the important Mercosur economic region while further complementing our business activities in Chile, Mexico and Brazil.
Sign-up for OPKO Health to Expand Latin American Presence with Acquisition of Uruguayan Pharmaceutical Company investment picks
2014/1/9
OPKO Health, Inc. (NYSE:OPK) today announced that senior management will present at the 32 nd Annual J.P. Morgan Healthcare Conference on Tuesday, January 14, 2014 at 4:30 PM Pacific Time.
Sign-up for OPKO Health to Present at the 32nd Annual J.P. Morgan Healthcare Conference investment picks
OPKO Health, Inc. (NYSE:OPK) today announced that senior management will present at the Oppenheimer 24 th Annual Healthcare Conference on Tuesday, December 10, 2013 at 10:55 AM (ET). OPKO’s senior management will provide a review of recent corporate developments.
Sign-up for OPKO Health to Present at the Oppenheimer 24th Annual Healthcare Conference investment picks
OPKO Health, Inc. (NYSE: OPK) announced that its Barcelona, Spain subsidiary, Pharmadiet, S.L.U. (“Pharmadiet”), received final marketing approval from Spain's health authority (Agencia Española de Medicamentos y Productos Sanitarios) for commercialization of its oral and injectable formulations of citicoline.
Sign-up for OPKO Obtains Final Marketing Authorization for Citicoline in Spain investment picks
OPKO Health, Inc. (NYSE: OPK ) has completed the sale of its stake in Sorrento Therapeutics, Inc. (NASDAQ: SRNE), a publicly-traded, clinical-stage biopharmaceutical company focused primarily on the acquisition, discovery, development and commercialization of proprietary therapeutics (“Sorrento”). The sale of Sorrento shares adds approximately $22 million to OPKO’s cash position and represents an approximate ten-fold return of OPKO’s 2009 investment.
Sign-up for OPKO Records Highly Successful Exit of Investment in Sorrento Therapeutics investment picks
OPKO Health, Inc.  (NYSE: OPK) , has surpassed 50% enrollment in the second phase 3 trial of  Rayaldy ™ to treat patients with secondary hyperparathyroidism (SHPT), stage 3 or 4 chronic kidney disease (CKD) and vitamin D insufficiency.
Sign-up for OPKO Surpasses 50% Enrollment in Second Phase 3 Trial of Rayaldy™ investment picks
OPKO Health, Inc. (NYSE: OPK) issued the following statement in response to inquiries about a report issued by Lakewood Capital Management challenging the potential of OPKO’s pipeline and business and investment initiatives: We are aware of the report, which we believe is based on distorted and inaccurate information.
Sign-up for OPKO To Hold Investor Conference investment picks
2014/2/28
OPKO Health, Inc. (NYSE:OPK) today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to OPKO's longer-acting version of clotting Factor VIIa (Factor VIIa-CTP) for the treatment of bleeding episodes in patients with hemophilia A or B with inhibitors to Factor VIII or Factor IX.
Sign-up for OPKO's Longer-Acting Clotting Factor VIIa-CTP Receives Orphan Drug Designation in the U.S. investment picks
FREMONT, Calif., Oct.
Sign-up for Oplink Reports First Quarter Fiscal Year 2014 Financial Results investment picks
FREMONT, Calif., Aug.
Sign-up for Oplink Reports Fourth Quarter Fiscal Year 2013 Financial Results investment picks
2014/1/29
FREMONT, Calif., Jan.
Sign-up for Oplink Reports Second Quarter Fiscal Year 2014 Financial Results investment picks
FREMONT, Calif., Dec.
Sign-up for Oplink Security Solutions Now Available at Fry's Electronics, Amazon investment picks
2013/12/18
FREMONT, Calif., Dec.
Sign-up for Oplink Security to Showcase Plug-and-Play Home Security Solutions, New Innovations at CES 2014 investment picks
2014/3/6
FREMONT, Calif., March 6, 2014 (GLOBE NEWSWIRE) -- Oplink Communications, Inc. (Nasdaq:OPLK) , a leading provider of optical communication components, intelligent modules and subsystems, today announced that it will be demonstrating its 4x28G metro DWDM CFP at OFC 2014.
Sign-up for Oplink to Demonstrate Industry-Leading 4x28G Metro DWDM CFP at OFC 2014 investment picks
FREMONT, Calif., Sept.
Sign-up for Oplink to Introduce 100G Metro DWDM CFP Transceiver at ECOC 2013 investment picks
FREMONT, Calif., Oct.
Sign-up for Oplink to Report First Quarter Fiscal Year 2014 Results on October 31, 2013 investment picks
FREMONT, Calif., July 30, 2013 (GLOBE NEWSWIRE) -- Oplink Communications, Inc. (Nasdaq:OPLK) , a leading provider of photonic telecommunications components, intelligent modules and subsystem solutions, today announced that it will issue a press release reporting financial results for its fourth quarter of fiscal year 2013, ended June 30, 2013, immediately following the close of the market on August 8, 2013.
Sign-up for Oplink to Report Fourth Quarter Fiscal Year 2013 Results on August 8, 2013 investment picks
2014/1/21
FREMONT, Calif., Jan.
Sign-up for Oplink to Report Second Quarter Fiscal Year 2014 Results on January 29, 2014 investment picks
2014/2/19
FREMONT, Calif., Feb.
Sign-up for Oplink to Showcase Suite of Family Video Alarm and Alert Solutions at Mobile World Congress 2014 investment picks
2014/3/6
FREMONT, Calif., March 6, 2014 (GLOBE NEWSWIRE) -- Oplink Communications, Inc. (Nasdaq:OPLK) , a leading provider of optical communication components, intelligent modules and subsystems, today announced that it will be demonstrating its RayXpress™ ROADM subsystem platform at OFC 2014.
Sign-up for Oplink to Showcase the RayXpress(TM) Platform for Flexible Grid CDC ROADM at OFC 2014 investment picks
OPMEDIC GROUP announces agreement with Founding Doctors to take the corporation private for a cash consideration of $2.90 per share Canada NewsWire Not for distribution to United States newswire services or for dissemination in the United States .
Sign-up for OPMEDIC GROUP announces agreement with Founding Doctors to take the corporation private for a cash consideration of $2.90 per share investment picks
2013/11/1
OPMEDIC GROUP announces results of special meeting of shareholders Canada NewsWire /NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES / MONTREAL , Nov.
Sign-up for OPMEDIC GROUP announces results of special meeting of shareholders investment picks
OPMEDIC Group completes going-private transaction Canada NewsWire /NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES / MONTREAL , Nov.
Sign-up for OPMEDIC Group completes going-private transaction investment picks
OPMEDIC GROUP Inc. announces the acquisition of the operations of Heartland Fertility and Gynecology Clinic in Winnipeg Canada NewsWire Not for distribution to United States newswire services or for dissemination in the United States .
Sign-up for OPMEDIC GROUP Inc. announces the acquisition of the operations of Heartland Fertility and Gynecology Clinic in Winnipeg investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: OPKO Health Announces Key Executive Appointments for Renal Division to OPMEDIC GROUP Inc. announces the acquisition of the operations of Heartland Fertility and Gynecology Clinic in Winnipeg
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity